| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 8:00–9:00 AM | Welcome and Keynote Address (Joint) |
| Alexandra Trkola, University of Zürich HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure |
| 9:00–11:15 AM | Immune Interventions Interfacing HIV Prevention and Cure (Joint) |
| Mauricio A. Martins, University of Florida Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer |
| Devi SenGupta, Gilead Sciences, Inc. Long-acting ART in HIV Prevention and Cure |
| Leonidas Stamatatos, Fred Hutchinson Cancer Research Center Vaccination of PLWH, using 426C Derived Immunogens |
| Short Talk(s) Chosen from Abstracts |
| 9:30–9:50 AM | Coffee Break |
| 11:15–1:00 PM | Poster Setup |
| 11:15–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 2:30–4:30 PM | Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Immune Targeting of HIV-1 Reservoir Cells: Obstacles and Opportunities |
| Brad Jones, Weill Cornell Medicine HIV Reservoir Cell Resistance to Immune-Mediated Killing |
| Michel C. Nussenzweig, HHMI/Rockefeller University HIV-1 Reservoir Dynamics |
| Kiera L. Clayton, University of Massachusetts Medical School NK Cell Targeting of the HIV Reservoir |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 1 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Tailoring Gene- and Cell-Therapy Approaches for HIV Cure: Promises and Pitfalls |
| Afam Okoye, Oregon Health & Science University Optimizing T Cell Responses for Post-ART Control |
| James L. Riley, University of Pennsylvania Immune-Based Cell Therapies |
| Lydie Trautmann, Military HIV Research Program Therapeutic Vaccine Trials in Humans |
| Daniel Dornbusch, Excision Bio Inc. CRISPR for HIV Cure: Human Clinical Trial Data |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–1:00 PM | Poster Setup |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 1:30–2:45 PM | Panel: Perspectives: Personalized Medicine & Patient-Centered Strategies (Joint) |
| 3:00–4:30 PM | Career Roundtable (Joint) |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Mechanisms of HIV Persistence: Insights and Innovations |
| Mathias Lichterfeld, Brigham and Women's Hospital Epigenetic Mechanisms of HIV Persistence |
| Roy Matkovic, Université de Paris, Institut Cochin The HUSH Complex and HIV Silencing |
| Nomonde Bengu, Umkhuseli Innovations Sex Differences in HIV Reservoir Cell Persistence |
| Short Talk(s) Chosen from Abstracts |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 2 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | No One Left Behind: HIV Cure Research Across the Age Continuum |
| Caroline T. Tiemessen, National Institute for Communicable Diseases HIV Immune Responses Across the Age Spectrum |
| Deborah Persaud, Johns Hopkins University School of Medicine HIV Remission in Infants |
| Roger Shapiro, Harvard School of Public Health Triple Combinations of Broadly-Neutralizing Antibodies in Children |
| Catherine K. Koofhethile, Botswana Harvard Health Partnership Viral Reservoirs and Immune Responses in Adolescents and Young Adults with HIV |
| Short Talk(s) Chosen from Abstracts |
| 9:00–9:20 AM | Coffee Break |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions |
| Short Talks Chosen from Abstracts |
| 4:30–5:00 PM | Coffee Available |
| 5:00–6:45 PM | B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint) |
| Marina F. Caskey, Rockefeller University Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies |
| Paula M. Cannon, University of Southern California, Keck School of Medicine Engineering B Cells as in vivo bnAb Factories |
| William Schief, The Scripps Research and IAVI Combining Germline Targeting Approaches Across Diverse bNAb Epitopes |
| Short Talk(s) Chosen from Abstracts |
| 6:45–7:00 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
| 7:00–8:00 PM | Social Hour with Dinner |
| 8:00–11:00 PM | Entertainment |
| 8:00–11:00 PM | Cash Bar |
| 12:00–11:59 PM | Departure |